Reply to 'Concerns about 2015 ERC Guidelines on pre-hospital use of ADP-receptor antagonists in patients with STEMI (ACS 335)'.

Woolfrey KG, Nikolaou NI, Welsford M.


http://www.ncbi.nlm.nih.gov/pubmed/26836945